Increasing doses of KM-819, a potential therapy being developed by Fascinate Therapeutics for Parkinson’s disease, showed a favorable safety…
Articles by Patricia Inácio, PhD
FGF-1, Zhittya Genesis Medical’s treatment candidate, appeared safe and effective at improving motor and cognitive function in the first …
Both type 2 diabetes and prediabetes — a condition in which blood sugar levels are abnormally high, but not high…
Among people undergoing surgery to remove a damaged spinal disc in the neck, those with Parkinson’s disease had significantly…
Changes in the structure of 76 proteins in the cerebrospinal fluid (CSF) of people with Parkinson’s disease were seen when…
Metabolon is teaming up with Tracking Parkinson’s, the world’s largest long-term study into Parkinson’s disease, to identify…
Highland Instruments will use its new technology — called the Integrated Motion Analysis Suite or IMAS — to objectively…
Early studies in nerve cells and a rat model of Parkinson’s disease support the potential of fosgonimeton, also known…
InMed Pharmaceuticals will launch a new program – the INM-900 series – that will investigate the therapeutic potential of…
MeiraGTx’s new Phase 1/2 clinical trial of AAV-GAD, its investigational gene therapy for Parkinson’s disease, has…